What Analysts Are Saying About Plexus Stock
Benzinga Insights 9 months ago
Analyst Ratings
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Plexus (NASDAQ:PLXS) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 1 | 0 | 0 |
| Last 30D | 2 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $203.2, a high estimate of $220.00, and a low estimate of $195.00. This current average has increased by 16.78% from the previous average price target of $174.00.
Breaking Down Analyst Ratings: A Detailed Examination
In examining recent analyst actions, we gain insights into how financial experts perceive Plexus. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Ruben Roy | Stifel | Raises | Hold | $200.00 | $150.00 |
| David Williams | Benchmark | Raises | Buy | $220.00 | $195.00 |
| James Ricchiuti | Needham | Raises | Buy | $206.00 | $165.00 |
| David Williams | Benchmark | Maintains | Buy | $195.00 | $195.00 |
| David Williams | Benchmark | Raises | Buy | $195.00 | $165.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Plexus. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Plexus compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Plexus's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Plexus's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Plexus analyst ratings.
All You Need to Know About Plexus
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
Plexus: A Financial Overview
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining Plexus's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.09% as of 31 December, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Plexus's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 3.85%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Plexus's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.81%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Plexus's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.3%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Plexus's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyst Ratings: What Are They?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.